Genetic basis of hyperlysinemia

[1]  Samuel Bouyain,et al.  Receptor‐type tyrosine phosphatase ligands: looking for the needle in the haystack , 2013, The FEBS journal.

[2]  T. Wieland,et al.  DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria. , 2012, American journal of human genetics.

[3]  S. Kölker,et al.  Cerebral Organic Acid Disorders and Other Disorders of Lysine Catabolism , 2012 .

[4]  Jean-Léon Thomas,et al.  A complex between contactin-1 and the protein tyrosine phosphatase PTPRZ controls the development of oligodendrocyte precursor cells , 2011, Proceedings of the National Academy of Sciences.

[5]  R. Hennekam,et al.  The atypical 16p11.2 deletion: A not so atypical microdeletion syndrome? , 2011, American journal of medical genetics. Part A.

[6]  G. Leipnitz,et al.  Neurochemical Evidence that Lysine Inhibits Synaptic Na+,K+-ATPase Activity and Provokes Oxidative Damage in Striatum of Young Rats In vivo , 2011, Neurochemical Research.

[7]  P. Zaratin,et al.  A novel role for receptor like protein tyrosine phosphatase zeta in modulation of sensorimotor responses to noxious stimuli: Evidences from knockout mice studies , 2009, Behavioural Brain Research.

[8]  G. Leipnitz,et al.  Inhibition of creatine kinase activity by lysine in rat cerebral cortex , 2009, Metabolic Brain Disease.

[9]  G. Leipnitz,et al.  Lysine induces lipid and protein damage and decreases reduced glutathione concentrations in brain of young rats , 2008, International Journal of Developmental Neuroscience.

[10]  N. Blau,et al.  Laboratory guide to the methods in biochemical genetics , 2008 .

[11]  D. Rabier,et al.  Biomarkers identified in inborn errors for lysine, arginine, and ornithine. , 2007, The Journal of nutrition.

[12]  M. Baumgartner,et al.  Mutations in antiquitin in individuals with pyridoxine-dependent seizures , 2006, Nature Medicine.

[13]  S. K. Wadman,et al.  Familial hyperlysinaemia due to L-lysineα-ketoglutarate reductase deficiency: Results of attempted treatment , 1978, Journal of Inherited Metabolic Disease.

[14]  D. Rabier,et al.  Plasma Lysine Concentration and Availability of 2-Ketoglutarate in Liver Mitochondria , 2002, Journal of Inherited Metabolic Disease.

[15]  J. Buxbaum,et al.  A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions , 2002, Nature Genetics.

[16]  R P Cox,et al.  Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia. , 2000, American journal of human genetics.

[17]  K. Goodman,et al.  Cloning of glutaryl-CoA dehydrogenase cDNA, and expression of wild type and mutant enzymes in Escherichia coli. , 1995, Human molecular genetics.

[18]  M. Baumgartner,et al.  Inborn Metabolic Diseases , 1995, Springer Berlin Heidelberg.

[19]  N. Beail,et al.  Dietary treatment of hyperlysinaemia. , 1989, Archives of disease in childhood.

[20]  D. Chuang,et al.  Familial hyperlysinemias. Purification and characterization of the bifunctional aminoadipic semialdehyde synthase with lysine-ketoglutarate reductase and saccharopine dehydrogenase activities. , 1984, The Journal of biological chemistry.

[21]  V. Shih,et al.  The prognosis of hyperlysinemia: an interim report. , 1983, American journal of human genetics.

[22]  S. Cederbaum,et al.  Hyperlysinemia with saccharopinuria due to combined lysine-ketoglutarate reductase and saccharopine dehydrogenase deficiencies presenting as cystinuria. , 1979, The Journal of pediatrics.

[23]  B. Korsch,et al.  Renal retransplantation in children. , 1979, The Journal of pediatrics.

[24]  N. C. Woody,et al.  Excretion of Pipecolic Acid by Infants and by Patients with Hyperlysinemia , 1970, Pediatric Research.

[25]  J. Dancis,et al.  Familial hyperlysinemia with lysine-ketoglutarate reductase insufficiency. , 1969, The Journal of clinical investigation.

[26]  H D Dakin,et al.  On Amino-acids. , 1918, The Biochemical journal.